Clinical Trial

Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This randomized controlled trial at Sahiwal Teaching Hospital (April 2024-March 2025) compared azithromycin and erythromycin for managing preterm premature rupture of membranes (PPROM) in 250 women (28-33+6 weeks gestation). Participants received either azithromycin 500 mg once daily or erythromycin 250 mg every six hours for seven days.
Trial Details
NCT Number NCT07394725
Lead Sponsor District Headquarters Teaching Hospital Sahiwal
Conditions Pre-term Premature Rupture of Membranes
Enrollment 250 participants
Start Date 2024-04-01
Primary Completion 2025-03-31 (estimated)
Study Completion 2025-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-06